DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Oxamic Acid is an investigational drug.
There have been 132 clinical trials for Oxamic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2013.
The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are National Cancer Institute (NCI), Merck Sharp & Dohme Corp., and M.D. Anderson Cancer Center.
There is one US patent protecting this investigational drug and eight international patents.
Recent Clinical Trials for Oxamic Acid
|Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma||National Cancer Institute (NCI)||Phase 2|
|Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma||M.D. Anderson Cancer Center||Phase 2|
|Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer||Merck Sharp & Dohme Corp.||Phase 2|
Top disease conditions for Oxamic Acid
Top clinical trial sponsors for Oxamic Acid
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Oxamic Acid||Start Trial||Process for the preparation of oxalyl- and oxamyl-hydrazides||Enichim ANIC S.p.A. (Palermo, IT)||Start Trial|
|Oxamic Acid||Start Trial||Novel fluorinated resorcinol ethers and their use as anti-allergics and anti-inflammatories||Ciba-Geigy Corporation (Ardsley, NY)||Start Trial|
|Oxamic Acid||Start Trial||Simultaneous assay for glucose and urea||Abbott Laboratories (Abbott Park, IL)||Start Trial|
|Oxamic Acid||Start Trial||N-acetylmannosamine dehydrogenase, process for its production, method for quantitatively analyzing N-acetylmannosamine or sialic acid, and kit for the quantitative analysis||Noda Institute for Scientific Research (Noda, JP)||Start Trial|
|Oxamic Acid||Start Trial||N,N'-hydrocarbylenebis[N-hals-substituted amic acid hydrazides] and their derivatives||Atochem North America, Inc. (Philadelphia, PA)||Start Trial|
|Oxamic Acid||Start Trial||Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain||Meiji Seika Kaisha, Ltd. (JP)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Oxamic Acid||Austria||78246||2008-04-21||Start Trial|
|Oxamic Acid||Germany||68902078||2008-04-21||Start Trial|
|Oxamic Acid||European Patent Office||0338387||2008-04-21||Start Trial|
|Oxamic Acid||Spain||2042850||2008-04-21||Start Trial|
|Oxamic Acid||Greece||3005201||2008-04-21||Start Trial|
|Oxamic Acid||Italy||1218223||2008-04-21||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|